Výsledky vyhledávání
- 1.TRSOVA, I.; HRUSTINCOVA, A.; KREJCIK, Z.; KUNDRAT, D.; HOLOUBEK, A.; STAFLOVA, K.; JANSTOVA, L.; VANIKOVA, S.; SZIKSZAI, K.; KLEMA, J.; RYSAVY, P.; BELICKOVA, M.; KAISRLIKOVA, M.; VESELA, J.; CERMAK, J.; JONASOVA, A.; DOSTAL, J.; FRIC, J.; MUSIL, J.; DOSTALOVA MERKEROVA, M.G Expression of circular RNAs in myelodysplastic neoplasms and their association with mutations in the splicing factor gene SF3B1. Molecular oncology. 2023, vol. 17, no. 12, s. 2565-2583. ISSN 1574-7891.
- 2.DOSTALOVA MERKEROVA, M.G; KLEMA, J.; KUNDRAT, D.; SZIKSZAI, K.; KREJCIK, Z.; HRUSTINCOVA, A.; TRSOVA, I.; LE, A.V.; CERMAK, J.; JONASOVA, A.; BELICKOVA, M. Noncoding RNAs and their response predictive value in azacitidine-treated patients with myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes. Cancer genomics and proteomics. 2022, vol. 19, no. 2, s. 205-228. ISSN 1109-6535.
- 3.DOSTALOVA MERKEROVA, M.; KUNDRAT, D.; KREJCIK, Z.; HRUSTINCOVA, A.; TRSOVA, I.; SZIKSZAI, K.; KAISRLIKOVA, M.; VESELA, J.; KLEMA, J.; CERMAK, J.; BELICKOVA, M. Circular RNAs in myelodysplastic syndromes and impact of SF3B1 mutations on their expression.
- 4.DOSTALOVA MERKEROVA, M.; SZIKSZAI, K.; KREJCIK, Z.; KLEMA, J.; HRUSTINCOVA, A.; KUNDRAT, D.; PECHERKOVA, P.; CERMAK, J.; JONASOVA, A.; BELICKOVA, M. LncRNA profiling reveals that the deregulation of H19, WT1-AS, TCL6, and LEF1-AS1 is associated with higher-risk myelodysplastic syndrome. [Prezentováno: 21. pražské hematologické dny: hematologie 2021: post-ASH. Praha, 28.1.-29.1.2021.].
- 5.KORALKOVA, P.; BELICKOVA, M.G; KUNDRAT, D.; DOSTALOVA MERKEROVA, M.; KREJCIK, Z.; SZIKSZAI, K.; KAISRLIKOVA, M.; VESELA, J.; VYHLIDALOVA, P.; STETKA, J.; HLAVACKOVA, A.; SUTTNAR, J.; FLODR, P.; STRITESKY, J.; JONASOVA, A.; CERMAK, J.; DIVOKY, V. Low plasma citrate levels and specific transcriptional signatures associated with quiescence of CD34+ progenitors predict Azacitidine therapy failure in MDS/AML patients. Cancers. 2021, vol. 13, no. 9, art. no. 2161. ISSN 2072-6694.
- 6.HRUSTINCOVA, A.; KREJCIK, Z.; KUNDRAT, D.; SZIKSZAI, K.; BELICKOVA, M.; PECHERKOVA, P.; KLEMA, J.; VESELA, J.; HRUBA, M.; CERMAK, J.; HRDINOVA, T.; KRIJT, M.; VALKA, J.; JONASOVA, A.; MERKEROVA, M.D.G Circulating small noncoding RNAs have specific expression patterns in plasma and extracellular vesicles in myelodysplastic syndromes and are predictive of patient outcome. Cells. 2020, vol. 9, no. 4, art. no. E794. ISSN 2073-4409.
- 7.SZIKSZAI, K.; KREJCIK, Z.; KLEMA, J.; LOUDOVA, N.; HRUSTINCOVA, A.; BELICKOVA, M.; HRUBA, M.; VESELA, J.; STRANECKY, V.; KUNDRAT, D.; PECHERKOVA, P.; CERMAK, J.; JONASOVA, A.; DOSTALOVA MERKEROVA, M.G LncRNA profiling reveals that the deregulation of H19, WT1-AS, TCL6, and LEF1-AS1 is associated with higher-risk myelodysplastic syndrome. Cancers. 2020, vol. 12, no. 10, art. no. 2726. ISSN 2072-6694.
- 8.DOSTALOVA MERKEROVA, M.G; KREJCIK, Z.; SZIKSZAI, K.; KUNDRAT, D. Circular RNAs in hematopoiesis with a focus on acute myeloid leukemia and myelodysplastic syndrome. International journal of molecular sciences. 2020, vol. 21, no. 17, art. no E5972. ISSN 1422-0067.
- 9.HRUŠTINCOVÁ, A.; SZIKSZAI, K.; KREJČÍK, Z.; LOUDOVÁ, N.; DOSTÁLOVÁ MERKEROVÁ, M. Noncoding RNAs in myelodysplastic syndromes. In: FUCHS, O. (ed.) Recent developments in myelodysplastic syndromes [online]. London: IntechOpen, 2019, s. 85-99. ISBN 978-1-78985-478-7. Dostupný z WWW: <https://doi.org/10.5772/intechopen.79767>.
- 10.HRUBÁ, M.; VESELÁ, J.; VOSTRÝ, M.; VOTAVOVÁ, H.; DOSTÁLOVÁ MERKEROVÁ, M.; SZIKSZAI, K.; KUNDRÁT, D.; LAUERMANNOVÁ, M.; SOUKUPOVÁ MAALOUFOVÁ, J.; ZEMANOVÁ, Z.; JONÁŠOVÁ, A.; ČERMÁK, J.; BELIČKOVÁ, M. Mutace genu RUNX1 doprovázenédysregulací dráhy buněčné senescence souvisí s rychlou progresí onemocnění u MDS pacientů s nízkým rizikem. In: CETKOVSKÝ, P.; WALDMANNOVÁ, K.; HOCHELOVÁ, I. (eds.) Sborník abstrakt: 19. pražský hematologický den. Praha: ÚHKT, 2019, s. 26. ISBN 978-80-906246-3-4.